Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Keros Therapeutics, Inc. (KROS)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
4 Nov 2023
Regnante Keith
Chief Financial Officer, Officer
Keros Therapeutics, Inc.
(KROS)
0
-100%
40,000
$45.29
$1,811,600.00
SELL
8 Jun 2023
Regnante Keith
Chief Financial Officer, Officer
Keros Therapeutics, Inc.
(KROS)
4,007
-90%
40,000
$46.61
$1,864,239.40
SELL
15 Jul 2022
Lachey Jennifer
Chief Scientific Officer, Officer
Keros Therapeutics, Inc.
(KROS)
95,100
-32%
46,034
$30.00
$1,381,020.00
SELL
13 Jul 2022
Lachey Jennifer
Chief Scientific Officer, Officer
Keros Therapeutics, Inc.
(KROS)
95,100
-1%
1,916
$30.00
$57,480.00
SELL
11 May 2022
Lachey Jennifer
Chief Scientific Officer, Officer
Keros Therapeutics, Inc.
(KROS)
87,602
-5%
5,300
$41.90
$222,049.61
SELL
11 Apr 2022
Lachey Jennifer
Chief Scientific Officer, Officer
Keros Therapeutics, Inc.
(KROS)
89,583
-5%
5,300
$62.77
$332,704.53
SELL
6 Apr 2022
Rovaldi Christopher
Chief Operating Officer, Officer
Keros Therapeutics, Inc.
(KROS)
0
-100%
1,728
$65.00
$112,320.00
SELL
4 Apr 2022
Lachey Jennifer
Chief Scientific Officer, Officer
Keros Therapeutics, Inc.
(KROS)
85,700
-8%
7,950
$60.00
$477,000.00
SELL
1 Apr 2022
Rovaldi Christopher
Chief Operating Officer, Officer
Keros Therapeutics, Inc.
(KROS)
862
-50%
864
$57.49
$49,675.08
SELL
11 Mar 2022
Lachey Jennifer
Chief Scientific Officer, Officer
Keros Therapeutics, Inc.
(KROS)
87,288
-2%
2,650
$53.38
$141,448.84
SELL
11 Feb 2022
Lachey Jennifer
Chief Scientific Officer, Officer
Keros Therapeutics, Inc.
(KROS)
87,277
-2%
2,650
$52.06
$137,964.70
SELL
11 Jan 2022
Lachey Jennifer
Chief Scientific Officer, Officer
Keros Therapeutics, Inc.
(KROS)
88,030
-2%
2,650
$53.75
$142,447.27
SELL
5 Jan 2022
Lachey Jennifer
Chief Scientific Officer, Officer
Keros Therapeutics, Inc.
(KROS)
85,700
-2%
2,650
$60.00
$159,000.00
SELL
3 Jan 2022
Knowles Julius
Director
Keros Therapeutics, Inc.
(KROS)
343,597
-12%
47,651
$57.84
$2,756,115.80
SELL
13 Dec 2021
Lachey Jennifer
Chief Scientific Officer, Officer
Keros Therapeutics, Inc.
(KROS)
85,700
-2%
2,650
$50.40
$133,558.25
SELL
1 Dec 2021
Knowles Julius
Director
Keros Therapeutics, Inc.
(KROS)
385,673
-10%
47,651
$54.09
$2,577,375.50
SELL
10 Nov 2021
Lachey Jennifer
Chief Scientific Officer, Officer
Keros Therapeutics, Inc.
(KROS)
90,261
-19%
21,200
$59.91
$1,270,058.00
SELL
4 Nov 2021
Lachey Jennifer
Chief Scientific Officer, Officer
Keros Therapeutics, Inc.
(KROS)
85,700
-11%
10,600
$50.00
$530,000.00
SELL
1 Nov 2021
Knowles Julius
Director
Keros Therapeutics, Inc.
(KROS)
402,854
-10%
47,651
$42.12
$2,007,129.40
SELL
19 Oct 2021
Knowles Julius
Director
Keros Therapeutics, Inc.
(KROS)
430,340
-1%
8,598
$38.20
$328,440.88
SELL
14 Oct 2021
Knowles Julius
Director
Keros Therapeutics, Inc.
(KROS)
433,394
-5%
26,367
$38.56
$1,016,652.70
SELL
1 Oct 2021
Knowles Julius
Director
Keros Therapeutics, Inc.
(KROS)
449,261
-2%
12,686
$40.10
$508,754.97
SELL
27 Sep 2021
Knowles Julius
Director
Keros Therapeutics, Inc.
(KROS)
487,249
-16%
95,302
$41.17
$3,924,003.20
SELL
1 Jul 2021
Knowles Julius
Director
Keros Therapeutics, Inc.
(KROS)
520,411
-8%
47,652
$41.31
$1,968,351.80
SELL
11 Jun 2021
Lachey Jennifer
Chief Scientific Officer, Officer
Keros Therapeutics, Inc.
(KROS)
79,024
-3%
2,650
$50.98
$135,087.22
SELL
11 Jun 2021
Ordonez Claudia
Chief Medical Officer, Officer
Keros Therapeutics, Inc.
(KROS)
347
-74%
1,000
$50.99
$50,990.09
SELL
4 Jun 2021
Knowles Julius
Director
Keros Therapeutics, Inc.
(KROS)
550,506
-3%
19,415
$49.07
$952,613.00
SELL
1 Jun 2021
Knowles Julius
Director
Keros Therapeutics, Inc.
(KROS)
558,132
-4%
28,236
$49.71
$1,403,553.50
SELL
11 May 2021
Lachey Jennifer
Chief Scientific Officer, Officer
Keros Therapeutics, Inc.
(KROS)
71,187
-3%
2,650
$50.00
$132,500.00
SELL
11 May 2021
Ordonez Claudia
Chief Medical Officer, Officer
Keros Therapeutics, Inc.
(KROS)
0
-100%
1,000
$50.15
$50,150.00
SELL
3 May 2021
Knowles Julius
Director
Keros Therapeutics, Inc.
(KROS)
572,825
-7%
47,651
$57.27
$2,728,849.80
SELL
12 Apr 2021
Lachey Jennifer
Chief Scientific Officer, Officer
Keros Therapeutics, Inc.
(KROS)
75,489
-6%
5,300
$60.00
$318,026.38
SELL
12 Apr 2021
Ordonez Claudia
Chief Medical Officer, Officer
Keros Therapeutics, Inc.
(KROS)
600
-62%
1,000
$59.93
$59,926.26
SELL
6 Apr 2021
Knowles Julius
Director
Keros Therapeutics, Inc.
(KROS)
604,885
-1%
9,298
$58.81
$546,840.10
SELL
1 Apr 2021
Knowles Julius
Director
Keros Therapeutics, Inc.
(KROS)
622,909
-5%
38,353
$59.72
$2,290,536.50
SELL
11 Mar 2021
Lachey Jennifer
Chief Scientific Officer, Officer
Keros Therapeutics, Inc.
(KROS)
64,752
-7%
5,300
$64.48
$341,749.53
SELL
11 Mar 2021
Ordonez Claudia
Chief Medical Officer, Officer
Keros Therapeutics, Inc.
(KROS)
605
-62%
1,000
$64.56
$64,555.85
SELL
3 Mar 2021
Knowles Julius
Director
Keros Therapeutics, Inc.
(KROS)
635,365
-3%
23,959
$56.45
$1,352,499.20
SELL
1 Mar 2021
Knowles Julius
Director
Keros Therapeutics, Inc.
(KROS)
647,327
-3%
23,690
$61.13
$1,448,078.10
SELL
16 Feb 2021
Knowles Julius
Director
Keros Therapeutics, Inc.
(KROS)
660,379
-4%
28,617
$60.87
$1,742,043.20
SELL
11 Feb 2021
Lachey Jennifer
Chief Scientific Officer, Officer
Keros Therapeutics, Inc.
(KROS)
32,844
-13%
5,300
$64.91
$344,016.66
SELL
11 Feb 2021
Ordonez Claudia
Chief Medical Officer, Officer
Keros Therapeutics, Inc.
(KROS)
825
-54%
1,000
$64.84
$64,841.29
SELL
11 Feb 2021
Knowles Julius
Director
Keros Therapeutics, Inc.
(KROS)
679,390
-2%
19,029
$63.53
$1,208,936.00
BUY
17 Nov 2020
Pontifax Management 4 G.P. (2015) Ltd.
10% Owner
Keros Therapeutics, Inc.
(KROS)
2,288,151
+2%
60,000
$50.00
$3,000,000.00
BUY
17 Nov 2020
Nussbaum Ran
Director, 10% Owner
Keros Therapeutics, Inc.
(KROS)
2,288,151
+2%
60,000
$50.00
$3,000,000.00
BUY
17 Nov 2020
Kariv Tomer
Director, 10% Owner
Keros Therapeutics, Inc.
(KROS)
2,288,151
+2%
60,000
$50.00
$3,000,000.00
BUY
13 Apr 2020
ORBIMED ADVISORS LLC
Director
Keros Therapeutics, Inc.
(KROS)
1,119,812
+50%
375,200
$16.00
$6,003,200.00
BUY
13 Apr 2020
Pontifax Management 4 G.P. (2015) Ltd.
10% Owner
Keros Therapeutics, Inc.
(KROS)
2,261,517
+23%
437,499
$16.00
$6,999,984.00
BUY
13 Apr 2020
Seehra Jasbir
Chief Executive Officer, Director, Officer
Keros Therapeutics, Inc.
(KROS)
243,856
+8%
20,000
$16.00
$320,000.00
BUY
13 Apr 2020
GORDON CARL L
Director
Keros Therapeutics, Inc.
(KROS)
1,119,812
+50%
375,200
$16.00
$6,003,200.00
BUY
13 Apr 2020
Arkin Bio Ventures Limited Partnership
10% Owner
Keros Therapeutics, Inc.
(KROS)
2,013,102
+6%
120,000
$16.00
$1,920,000.00
BUY
13 Apr 2020
Kariv Tomer
Director, 10% Owner
Keros Therapeutics, Inc.
(KROS)
2,261,517
+23%
437,499
$16.00
$6,999,984.00
BUY
13 Apr 2020
Lazarus Alon
Director, 10% Owner
Keros Therapeutics, Inc.
(KROS)
2,013,102
+6%
120,000
$16.00
$1,920,000.00
BUY
13 Apr 2020
Nussbaum Ran
Director, 10% Owner
Keros Therapeutics, Inc.
(KROS)
2,261,517
+23%
437,499
$16.00
$6,999,984.00
BUY
13 Apr 2020
Knowles Julius
Director
Keros Therapeutics, Inc.
(KROS)
1,191
+100%
1,191
$20.98
$24,987.18
Home